Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05432752 · ClinicalTrials.gov registry record · NA
Concussion Pen Screening Tool
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT05432752 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 21 participants.
The verdict
NCT05432752, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
To compare the use of the Concussion Pen to current clinical care practice. This will be a prospective study of a maximum of 24 subjects, with a goal enrollment of 20 subjects (10 in each cohort). All subjects will undergo clinical evaluation for concussion and will also be evaluated using the Concussion Pen. Randomization to being evaluated using clinical care first then the Concussion Pen and vice versa will be utilized. This randomization will help to control for evaluation fatigue on the part of study participants.
Interventions
- DEVICE Concussion Pen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2022-07-28 |
| Est. Completion | 2023-01-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05432752
The ClinicalTrials.gov registry entry for NCT05432752 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Concussion Pen is the first listed.
NCT05432752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05432752 about?
NCT05432752 is a clinical study titled "Concussion Pen Screening Tool". To compare the use of the Concussion Pen to current clinical care practice. This will be a prospective study of a maximum of 24 subjects, with a goal enrollment of 20 subjects (10 in each cohort). All subjects will undergo clinical evaluation for concussion and will also be evaluated using the Concu...
What is the current status of trial NCT05432752?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2022-07-28. Estimated completion is 2023-01-25.
What interventions are being tested in trial NCT05432752?
The interventions under investigation include: Concussion Pen (DEVICE).
Who is sponsoring clinical trial NCT05432752?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.